Aimei Health Technology Co., Ltd. is a blank check company, also known as a special purpose acquisition company (SPAC), incorporated in 2023 and headquartered in New York, NY. It has no significant operations of its own and exists primarily to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company focuses on opportunities in healthcare-related sectors, including biopharmaceuticals, medical technology and devices, diagnostics, and other services, though it remains open to targets across industries and geographies. Currently, it has entered into a definitive business combination agreement with United Hydrogen Group Inc. and related entities to form United Hydrogen Global Inc. as the combined public entity through a series of mergers. Aimei Health Technology Co., Ltd. raises capital via its initial public offering, holds proceeds in a trust account for public shareholders, and pursues completion of the transaction within an extendable timeframe, subject to shareholder approvals, redemptions, and regulatory conditions. Classified in the financial services sector as a shell company, it plays a key role in facilitating public market access for private businesses via the SPAC structure.